Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

No cure exists for alopecia areata, and treatments are personalized.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Some medications can cause acne, and stopping these drugs is the main treatment.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The new wound dressing with minoxidil and dexamethasone could speed up healing and reduce scarring in rats.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

Corticosteroids effectively treated a 60-year-old man's skin condition.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Stress can slow hair growth and affect skin color by impacting the body's stress response system.

Mercury can disrupt sex hormones and cause reproductive issues.

Hair follicles affect how well small molecules can pass through the skin, and this varies depending on the molecule's features.